8-KThe WireStrategic
Results of Operations · Bylaw Amendment
Filed Mar 10, 2026 · 3mo ago · Accession 0001193125-26-099404
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- 8-K
- Filing date
- Mar 10, 2026
- Report date
- Mar 6, 2026
- Document
- dmra-20260306.htm
- Size
- 238 KB